抑乳调经颗粒在健康女性志愿者中单次给药耐受性和安全性的开放、剂量递增的I期临床试验
[Translation] An open-label, dose-escalating phase I clinical trial of Yiru Tiaojing Granules in healthy female volunteers for single-dose tolerability and safety
评估在健康女性志愿者中,单次口服抑乳调经颗粒10 g、20 g、30 g、 或 40 g 后的安全性和耐受性。
[Translation] To evaluate the safety and tolerability of a single oral administration of 10 g, 20 g, 30 g, or 40 g of YRUTiaojing Granules in healthy female volunteers.
100 Clinical Results associated with
0 Patents (Medical) associated with
100 Deals associated with
100 Translational Medicine associated with